30 results
8-K
EX-1.1
NRBO
NeuroBo Pharmaceuticals Inc
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm
Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
424B4
NRBO
NeuroBo Pharmaceuticals Inc
7 Nov 22
Prospectus supplement with pricing info
9:07am
, such as a “boxed” warning or a contraindication;
we may be required to recall the product, change the way such product candidates are distributed … ;
recall of products;
fines, restitution or disgorgement of profits or revenue;
suspension or withdrawal of marketing approvals for the drug products
8-K
EX-10.1
6buk7hzx
4 Oct 21
Neurobo Pharmaceuticals Announces $14 Million Registered Direct Offering
4:46pm
8-K
EX-10.1
opu4ktl0xrq5t 6z28
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-10.1
wj2trqi9j
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
424B3
1u095kl42noiz95ak
6 Nov 19
Prospectus supplement
9:15am
S-4/A
kxj1x3h03ihm
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4
varyb30zj um
3 Sep 19
Registration of securities issued in business combination transactions
12:00am